First Trust Small Cap Core AlphaDex

Arrowhead Pharmaceuticals CEO Sells Company Common Stock

Globalstar and Skydio Successfully Complete Drone Technology Trial

Harmony Biosciences Collaborates with Beacon Biosignals to Advance Narcolepsy Clinical Trials

Marex Group Buys Arrowhead Pharmaceuticals Shares in Q2

Planet Labs PBC Reports Robust Earnings and Raises 2026 Fiscal Guidance

Deutsche Bank Raises Planet Labs Target Price, Shares Surge

Kohl's CFO sells company stock

UBS Asset Management Reduced Stake in Praxis Precision Medicines in Q2

RBC Raises Arrowhead Pharmaceuticals Target Price to $80

Michael Latimore and Jeff Van Rhee Maintain Buy Rating on Planet Labs PBC

Analyst Maintains Buy Rating on Planet Labs PBC

Praxis Precision Plans to Submit New Drug Application for Relutrigine in Early 2026

HighVista Strategies LLC Increased its Stake in Praxis Precision Medicines

Planet Labs Surpasses Expectations, Post-Earnings Stock Soars

Planet Labs released FY2026 Q3 earnings on December 10 After-Market EST, actual revenue USD 81.25 M (forecast USD 72.02 M), actual EPS USD -0.1913 (forecast USD -0.0833)

Planet Labs released FY2026 9 Months earnings on December 10 After-Market EST, actual revenue USD 220.91 M, actual EPS USD -0.3077

Photronics released FY2025 Q4 earnings on December 10 Pre-Market (EST), actual revenue USD 215.77 M (forecast USD 204.54 M), actual EPS USD 1.07 (forecast USD 0.445)

Photronics released FY2025 annual earnings on December 10 Pre-Market EST, actual revenue USD 849.29 M (forecast USD 838.05 M), actual EPS USD 2.28 (forecast USD 1.68)

Kohl's Extends Partnership with Hunger Task Force and Provides $750,000

Arrowhead Pharmaceuticals Inc. Director Michael S. Perry Sells Common Stock

Vision Marine Tech

AMC Robotics

SRX Health Solutions

B Riley Financial

Cementos Pacasmayo Saa 

Everbright Digital

Adagio Medical

Emerald

ChowChow Cloud

AdvisorShares MSOS 2x Daily ETF

ARWR

Chairman Christopher Richard Anzalone of Arrowhead Pharmaceuticals Inc [ARWR] surrendered 184,298 shares at $67.00 each, valued at $12,348,814, to pay for option exercise costs and/or tax liabilities. His ending holdings are 3,916,957 shares. This was disclosed in a Form 4 filed with the SEC on December 16, 2025.

Reuters

ArrowHead Pharma

Chmn Anzalone Surrenders 184,298 Of Arrowhead Pharmaceuticals Inc [ARWR]

Arrowhead Pharmaceuticals CEO Christopher Richard Anzalone reported the sale of common shares of the company. The information was published via EDGAR by the U.S. Securities and Exchange Commission on December 16, 2025. This news brief was generated by Public Technologies using AI and is for informational purposes only.

Arrowhead Pharmaceuticals CEO Christopher Richard Anzalone Reports Sale of Common Shares

GSAT

Globalstar and Skydio have successfully completed a technology trial, validating Skydio's drones on Globalstar's licensed Band n53 spectrum and XCOM RAN private 5G platform. This trial demonstrated the compatibility and high performance of Band n53 and XCOM RAN for public safety applications, offering a reliable alternative to traditional networks. The collaboration aims to enhance connectivity for autonomous drones, supporting first responders with improved tools for safety and efficiency.

StockTitan

Globalstar

Globalstar and Skydio Complete First Drone Flight on Globalstar Band n53TM and XCOM RAN | GSAT Stock News

Kohl's Corp. (KSS) shares fell 4.68% to $22.18 on Monday, underperforming compared to competitors. The stock market had a generally grim session, with the S&P 500 Index down 0.16% and the Dow Jones Industrial Average down 0.09%. This marked Kohl's second consecutive day of losses, closing 12.05% below its 52-week high. Trading volume was 4.5M, below the 50-day average of 5.3M.

Dow Jones

Kohls

Kohl's Corp. Stock Underperforms Monday When Compared To Competitors

Arrowhead Pharmaceuticals Inc. has granted 141,310 restricted stock units to 78 new employees. These inducement grants will vest annually over four years and are provided outside the company's existing equity incentive plans. The announcement was made via Business Wire on December 15, 2025.

Arrowhead Pharmaceuticals Grants 141,310 Restricted Stock Units to New Employees

GOOGL

AMZN

NVDA

TSLA

RKLB

ASTS

SATS

To address the surge in AI computing power demand and ground power bottlenecks, American tech giants are collectively turning to the concept of "space data centers." Google plans to launch prototype testing satellites in 2027, while companies like SpaceX and Blue Origin are also accelerating their layouts. This trend is being driven by the decrease in launch costs and the reshaping of capital narratives, pushing the field from a technological vision into the early validation stage

- The explosive growth in AI's demand for computing power has led U.S. tech giants to explore the concept of "space data centers" to alleviate ground infrastructure bottlenecks.  
- Companies like Google and startups such as Starcloud are actively testing AI technologies in space, driven by the need for sustainable energy solutions and lower operational costs.  
- Despite concerns over radiation risks and maintenance challenges, the decreasing costs of rocket launches are making space data centers a viable commercial prospect, reshaping capital expenditure expectations in the hardware sector.

Wallstreetcn

Alphabet

Amazon

NVIDIA

Tesla

Rocket Lab

AST SpaceMobile

Planet Labs

Echostar

Destiny Tech100

Led by Musk, with Bezos and Jensen Huang joining in, the American tech circle suddenly has a "flood" of discussions about space data centers

Marex Group plc acquired 36,469 shares of Arrowhead Pharmaceuticals, Inc. during the 2nd quarter, valued at approximately $576,000. Several other hedge funds also modified their holdings in the company. Analysts have given Arrowhead Pharmaceuticals a 'Moderate Buy' rating with a consensus price target of $58.56. The stock opened at $70.09, with a market cap of $9.52 billion. Recent insider trading involved the sale of shares by directors Michael S. Perry and Mauro Ferrari.

Market Beat

Marex

36,469 Shares in Arrowhead Pharmaceuticals, Inc. $ARWR Acquired by Marex Group plc

Planet Labs' stock surged 35% after its backlog increased by 361% to $672 million, transitioning it from the Space Sector to AI Infrastructure elite. The market values its unique data as a finite resource, driving its stock to trade at 18x Forward Sales. Investors anticipate significant revenue growth from the backlog, but the high valuation carries execution risk.

Forbes

Up 35%, Why Planet Labs Just Tripled Its Backlog Overnight

Planet Labs PBC reported strong earnings with faster revenue growth and four consecutive quarters of adjusted EBITDA profit, leading to a guidance hike for fiscal 2026. The stock price surged to $18.24, marking a 359.45% year-to-date return. Despite this, the stock is considered overvalued with a fair value of $11.31. The company leads the Earth Observation market but faces risks in commercial adoption and government contracts. Investors are advised to consider these factors when evaluating the stock's future potential.

Simplywall

Planet Labs (PL) valuation after strong earnings, guidance hike, and major government wins in Earth observation and AI

Planet Labs PBC (NYSE:PL) shares surged after Deutsche Bank Aktiengesellschaft raised their price target from $16.00 to $17.00, opening at $18.44 from a previous close of $17.47. The stock has a buy rating from Deutsche Bank and other analysts. Insider Robert H. Schingler sold 81,656 shares. Institutional investors have increased their positions. The company reported a quarterly revenue of $81.25 million, up 32.6% year-over-year, but missed EPS estimates. Planet Labs designs and launches satellite constellations for geospatial data.

Planet Labs PBC (NYSE:PL) Shares Gap Up  on Analyst Upgrade

First Trust Small Cap Core AlphaDEX Fund (NASDAQ:FYX) announced a quarterly dividend of $0.3713 per share, a 37.9% increase from the previous $0.27. The dividend will be paid on December 31st to stockholders of record on December 12th, with an ex-dividend date of December 12th. The fund's stock opened at $117.86, with a 12-month range of $77.66 to $118.07, and a market cap of $966.45 million.

First Trust Small Cap Core AlphaDEX Fund (NASDAQ:FYX) to Issue Quarterly Dividend of $0.37

PLAB

Park Han Kyung, VP of Photronics Inc, filed a Form 144 with the SEC to sell 13,750 restricted shares on December 12, 2025, through Fidelity Brokerage Services. This filing allows the sale within 90 days.

Photronics

VP Park Files To Sell 13,750 Of Photronics Inc [PLAB]

Planet Labs shares hit a new all-time high, driven by a stellar Q3 earnings report. The company reported $81.3 million in revenue, a 33% YoY increase, and raised its full-year revenue guidance. The stock soared over 30%, with strong forward-looking metrics and significant contract wins. Analysts upgraded their price targets, and the stock shows strong momentum, trading well above its moving averages.

benzinga_article

Planet Labs Stock Hits A New All-Time High Friday: What's Going On?